GlassScriptPhysician profile
Matthew Scott Weinstein
NPI 1487115820
$3,309.05
in general payments reported to CMS, 2019-2025
14 companies · $2,072 in 2025
The $2,072 reported for 2025 was more than what 87% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.56 · 2023: $418 · 2024: $739 · 2025: $2,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,068 · Entertainment: $99.57 · Education: $32.08 · Travel and Lodging: $29.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,067.88 |
| Entertainment | $99.57 |
| Education | $32.08 |
| Travel and Lodging | $29.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $877.58 | 2023-2025 | Intellis Adaptivestim, Synchromedii |
| Forte Bio-Pharma LLC | $674.64 | 2025 | Prolate, Tanlor, Nalocet |
| Curonix LLC | $335.71 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $253.38 | 2024 | Mild Device Kit |
| Spinal Simplicity, LLC | $252.12 | 2025 | Ha Minuteman G3-R |
| Stryker Corporation | $247.16 | 2024 | Mild Device Kit |
| Boston Scientific Corporation | $157.69 | 2023 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.07 | 2025 | Relistor |
| Foundation Fusion Solutions, LLC | $125.60 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $103.48 | 2022-2025 | Xeomin |
| Vertex Pharmaceuticals Incorporated | $59.24 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $44.82 | 2024-2025 | Belbuca |
| Abbvie INC. | $21.36 | 2023 | Botox |
| Mml US, INC. | $4.20 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.